Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
about
The role of pneumolysin in pneumococcal pneumonia and meningitisA Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensInsights from Streptococcus pneumoniae glucose kinase structural modelRandomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsImmunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in MiceT(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationIdentification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.Host cellular immune response to pneumococcal lung infection in mice.Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.Pneumococcal virulence factors: structure and functionThe impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres.Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection.Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection.Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives.The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cellsThe Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease.Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniaeIdentification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults.Pneumococcal vaccination and revaccination of older adults.Next generation pneumococcal vaccinesA practical method for preparation of pneumococcal and nontypeable Haemophilus influenzae inocula that preserves viability and immunostimulatory activity.The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanismsRelative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniaeReduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxoneTwo DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood.Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniaeCharacterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccinesFunctional analysis of pneumolysin by use of monoclonal antibodies
P2860
Q24684269-3DA6E6B3-F6B0-4378-8F73-49227BAA3C6DQ26753152-366EBD6D-EAB2-48ED-9CAC-DFE6AD22FE1DQ30375623-687ECD50-322D-4F2D-8751-17756FAAF5C0Q33601853-0F99B96F-7EB6-471C-ACE2-D1CCD6B01568Q33675920-18446323-2774-4204-AD0C-C372326EFE5EQ33820413-1EE59E69-2753-44C2-88B2-347AEC70E916Q33826031-5BC79DEE-21FC-491E-96DD-8F329F017C90Q33975380-39815466-A923-4D45-B330-07AB7430A073Q34000846-170101F6-F995-414E-AB26-5E33B0E30598Q34002986-B9AF1827-94A0-4798-8937-571ABC6C2E38Q34003173-B3E28AB8-CEEA-43AD-A7DD-D4993FCB0B45Q34003306-273AA4ED-D320-4AAD-9336-49FD045CE0D8Q34004489-56D295A0-29EC-4C8F-81DC-81997C332634Q34009174-5233EBCF-F01B-4BE9-BE5A-D8179B126761Q34010335-E1170FC1-EB36-465C-90EE-C1BAB5E3A290Q34020348-AD2EAB42-C8D0-445B-9E5F-CFECDB1BB01EQ34120517-981E3234-4933-4BA0-AEA7-09D60C9919B0Q34120542-B991BAA6-4EA2-45EB-B3DC-851562482810Q34301234-85882821-E8F1-4C00-91B2-9C4F76A5D9BCQ34315525-FF37E492-3D31-4715-AF44-B19D94DBC220Q34444527-EC58C769-3199-4156-BBF6-8C6BE234935EQ34480440-C27906F4-0804-4AFD-9E4B-8A963B527D71Q34484575-7BAAB615-069D-4F04-84EB-10A6D65502E8Q34595710-DD0409CB-0BEF-4F32-B4D2-5A125EE2F9A4Q34637890-352F5B6B-7701-4482-AEEF-DA86012AC0AAQ34664198-7F033383-E0DC-4C64-A9F5-99300884B846Q34758260-C3A4A91A-D78F-4424-A5FE-61DBFD2C507AQ34852939-9F3E0895-964F-45ED-BC6B-213F3724A1E8Q34876231-B68AE545-7DDC-45F6-A197-B70F676DFC77Q34926870-B84000F4-8829-43F9-AA4F-F42A47DC2BB8Q35028495-447099CA-8105-4547-B36D-4E1D6C0DD16EQ35062832-5622216E-B643-431B-A7F0-0D4E2ED89DD8Q35073802-CF7BE96D-E8AE-4483-8BE4-7CE2208ADE6DQ35165275-0D53F346-0878-49E0-9B29-C3225C6249F8Q35166074-2DD2FC98-BD25-4668-AC29-E7BC53EFFCB3Q35191928-5D07CEBA-D459-4F90-A7AB-F4D0EADFAE67Q35272956-EE3B14B1-F5F6-46E7-BC98-4D1F511CD5F0Q35412350-5C0F0BAF-68F7-47E2-88EE-24E7E9EAC5C3Q35424204-0B57D9A6-6D0B-499E-81E3-DC82BE8C434BQ35467438-A7B91383-B433-4730-AB27-D163BF202272
P2860
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@ast
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@en
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@nl
type
label
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@ast
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@en
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@nl
prefLabel
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@ast
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@en
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@nl
P2093
P2860
P1476
Immunization of mice with pneu ...... es of Streptococcus pneumoniae
@en
P2093
C C Peeters
J E Alexander
J T Poolman
P W Andrew
P2860
P304
P407
P577
1994-12-01T00:00:00Z